Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Wunderlich

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
Der Urologe. Ausg. A|July 1, 1998
[Lymphocyte transformation test (LTT) as a model for evaluating cytokine-induced immunomodulation in renal cell carcinoma]T Steiner, U Junker, H Wunderlich, et al.
Scandinavian Journal of Urology and Nephrology|November 26, 1999
Comment on "Interference pattern in the urethral sphincter-a quantitative electromyographic study in patients before and after radical retropubic prostatectomy"D H Zermann, M Ishigooka, H Wunderlich, et al.
The Journal of Urology|May 1, 1997
Serum transforming growth factor-beta1 in patients with renal cell carcinomaH Wunderlich, T Steiner, U Junker, et al.
Urologia Internationalis|March 30, 2000
Multifocality in renal cell carcinoma: A bilateral event?H Wunderlich, A Schlichter, D Zermann, et al.
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|March 6, 1998
[Adrenal cortex insufficiency caused by metastatic tumors]H Wunderlich, I Heisig, A Schlichter, et al.
Oncology Reports|April 11, 2001
Fetal fibronectin: a new screening-marker for bladder cancer?H Wunderlich, O Reichelt, D H Zermann, et al.
Urologia Internationalis|August 8, 2001
Endocrine alteration in the adrenal gland in kidney transplant patientsH Wunderlich, D H Zermann, O Reichelt, et al.
Urologia Internationalis|July 21, 2001
Renal cell carcinoma in renal graft recipients and donors: incidence and consequenceH Wunderlich, S Wilhelm, O Reichelt, et al.
Journal of the American Chemical Society|April 12, 2012
Synthesis of (6-(13)C)pyrimidine nucleotides as spin-labels for RNA dynamicsChristoph H Wunderlich, Romana Spitzer, Tobias Santner, et al.
European Urology|April 15, 2000
Where are the limits of elective nephron- sparing surgery in renal cell carcinoma?A Schlichter, H Wunderlich, K Junker, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
Der Urologe. Ausg. A|July 1, 1998
[Lymphocyte transformation test (LTT) as a model for evaluating cytokine-induced immunomodulation in renal cell carcinoma]T Steiner, U Junker, H Wunderlich, et al.
Scandinavian Journal of Urology and Nephrology|November 26, 1999
Comment on "Interference pattern in the urethral sphincter-a quantitative electromyographic study in patients before and after radical retropubic prostatectomy"D H Zermann, M Ishigooka, H Wunderlich, et al.
The Journal of Urology|May 1, 1997
Serum transforming growth factor-beta1 in patients with renal cell carcinomaH Wunderlich, T Steiner, U Junker, et al.
Urologia Internationalis|March 30, 2000
Multifocality in renal cell carcinoma: A bilateral event?H Wunderlich, A Schlichter, D Zermann, et al.
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|March 6, 1998
[Adrenal cortex insufficiency caused by metastatic tumors]H Wunderlich, I Heisig, A Schlichter, et al.
Oncology Reports|April 11, 2001
Fetal fibronectin: a new screening-marker for bladder cancer?H Wunderlich, O Reichelt, D H Zermann, et al.
Urologia Internationalis|August 8, 2001
Endocrine alteration in the adrenal gland in kidney transplant patientsH Wunderlich, D H Zermann, O Reichelt, et al.
Urologia Internationalis|July 21, 2001
Renal cell carcinoma in renal graft recipients and donors: incidence and consequenceH Wunderlich, S Wilhelm, O Reichelt, et al.
Journal of the American Chemical Society|April 12, 2012
Synthesis of (6-(13)C)pyrimidine nucleotides as spin-labels for RNA dynamicsChristoph H Wunderlich, Romana Spitzer, Tobias Santner, et al.
European Urology|April 15, 2000
Where are the limits of elective nephron- sparing surgery in renal cell carcinoma?A Schlichter, H Wunderlich, K Junker, et al.
Pageof 9